Research groups around the world are working to find ways to implant or grow real biological teeth in a human jaw.

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

Scientists have uncovered a toxic alliance between Aβ and fibrinogen that may explain how Alzheimer’s disease begins. The two ...

At AAO 2025, Genentech reported that vamikibart, a first-in-class IL-6–targeted antibody, led to rapid improvements in visual acuity and macular thickness in patients with uveitic macular edema, ...

For decades, scientists have known that Alzheimer's disease is marked by sticky plaques and tangled proteins in the brain. In ...

Basel, 17 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today results from two phase III studies evaluating the efficacy and safety of two doses of investigational vamikibart (0.25 and 1 ...

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patientsVision improvements were seen in both pivot ...

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...

The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...

The presence of Tau and TDP-43 co-aggregates is associated with high Alzheimer’s disease (AD) severity, but whether there is ...

Mohawk Industries, Inc. (NYSE: MHK) today announced third quarter 2025 net earnings of $109 million and earnings per share (“EPS”) of $1.75; ...